Nurix Therapeutics Inc
NRIX·Stocks·Biotechnology·United States·Nasdaq·USD
Price
$22.74
Today
-1.1%
YTD
+21.3%
About
Established in 2009, Nurix Therapeutics, Inc. is a biotechnology firm developing therapies to help treat cancer and immune disorders. Operating within the US, the company has its headquarters in San Francisco, California. Stock for Nurix Therapeutics is available on the NASDAQ GM using the NRIX ticker. Add this instrument to your eToro watchlist to follow the latest NRIX stock news.
Price chart
Closing price history for NRIX (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.
Open positions
0
Unrealized return
+0.0%
No open positions exist for this instrument at the moment.
Financial insights
Valuation
P/E (TTM)-6.67
P/S (TTM)69.46
P/B (TTM)5.92
Market cap$2.39B
Cap tierMid-cap
Industry avg P/E-1.99
Profitability
Gross margin53.06%
EBIT margin-982.37%
Net margin-990.10%
ROE-80.30%
ROA-60.57%
Earnings & Revenue
Revenue (TTM)$36.77M
Revenue growth (1Y)-58.4%
EPS (TTM)-$3.45
Free cash flow$-304.53M
Total debt$58.14M
Dividends & Risk
Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.65
Employees317
Next earnings8 Oct '26
Trade history
Closed trades
0
Realized return
+0.0%
No stored closed trades exist for this instrument yet.